Brief: Exact Therapeutics - Grant Of Immunotherapy Patent
25/09/2024 08:11
Sept 25 (Reuters) - Exact Therapeutics AS EXTX.OL :
* ANNOUNCES GRANT OF IMMUNOTHERAPY PATENT
* WAS INFORMED THAT INTELLECTUAL PROPERTY OFFICE IN UNITED
KINGDOM
WILL TODAY GRANT EXACT ITS UK PATENT
Source text for Eikon: ID:nObi6l0qja
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial